Agilent Technologies (A) 58.07 $A
TRADE NEWS: Keysight Technologies Announces Best-in-Class Femto/Picoammeters and Electrometers for Research and Development of New Materials
Business Wire - Tue Sep 02, 10:00AM CDT
Keysight Technologies, Inc. today introduced the B2980A Series of femto/picoammeters and electrometers, the world's first graphical picoammeters and electrometers to confidently measure down to 0.01 fA which is 0.01 x 10-15 A, and up to 10 petaohms (P) which is 10 x 10(15) ohms.
Agilent Technologies Introduces Higher-Performance Q-TOF GC/MS System, Featuring Optimized Hardware/Software Capabilities
Business Wire - Tue Sep 02, 10:00AM CDT
Agilent Technologies Inc. (NYSE:A) today introduced the 7200B Quadrupole Time of Flight (Q-TOF) Gas Chromatography Mass Spectrometer (GC/MS) System. The system replaces the company's most advanced GC/QTOF, the 7200A, with new capabilities that will significantly boost laboratory performance.
Microlease Unveils Certified Pre-Owned Program
Business Wire - Tue Sep 02, 7:01AM CDT
Microlease, Inc. today announced the launch of Microlease Certified Pre-Owned, a comprehensive program to address growing customer demand for quality test instruments with guarantees and calibration. Microlease Certified Pre-Owned will include instruments from leading manufacturers including Keysight Technologies (formerly Agilent Technologies), Tektronix, JDSU, Anritsu, Rohde & Schwarz, and Keithley, among others.
Agilent Technologies the ClearSeq AML for next generation cancer research
M2 - Tue Sep 02, 3:51AM CDT
Agilent Technologies Inc (NYSE: A), a chemical analysis, life sciences, diagnostics, electronics and communications company, today introduced ClearSeq AML, the first product in the ClearSeq line of next-generation cancer research panels, which targets 48 selected exons in 20 of the most commonly mutated genes found in acute myeloid leukemia.
Agilent Technologies Introduces Next-Generation Sequencing Cancer Research Panels
Business Wire - Tue Sep 02, 2:30AM CDT
Agilent Technologies Inc. (NYSE: A) today introduced ClearSeq AML, the first product in the ClearSeq line of next-generation cancer research panels, which targets 48 selected exons in 20 of the most commonly mutated genes found in acute myeloid leukemia.
Dako Launches Fast HER2 ISH Assay for New Automated Staining Platform in Europe
GlobeNewswire - Mon Sep 01, 8:13AM CDT
Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics , today announced the EU launch of HER2 IQFISH pharmDx automated on Dako Omnis.
Global Nebulizers Market Industry Analysis 2014-2019 - Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers
M2 - Mon Sep 01, 3:38AM CDT
Research and Markets (http://www.researchandmarkets.com/research/l9s298/nebulizers_market) has announced the addition of the "Nebulizers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global nebulizers market was valued at USD 610.0 million in 2012 and is expected to grow at a CAGR of 6.5% from 2013 to 2019, to reach an estimated value of USD 937.7 million by 2019. The global nebulizers market is segmented based on product types into pneumatic nebulizer, ultrasonic nebulizer and mesh nebulizer. In 2012, pneumatic nebulizer accounted for the largest market share of the global nebulizers market owing to its cost effective nature and easy to handle. Pneumatic nebulizers are further classified as vented and breath-actuated pneumatic nebulizers. In 2012, breath actuated pneumatic nebulizers segment accounted for the largest share of the global pneumatic nebulizers market due to factors such as cost effectiveness and efficient drug delivery. Moreover, the breath-actuated pneumatic nebulizers segment is expected to grow at the highest CAGR from 2013 to 2019 in the global pneumatic nebulizers market. Ultrasonic nebulizers are further segmented into standalone and portable ultrasonic nebulizers. Portable ultrasonic nebulizers accounted for the largest share as they are easy to handle and operate. North America accounted for the largest share in the global nebulizers market in 2012 owing to rising prevalence of respiratory diseases such as asthma, COPD and cystic fibrosis. In addition, increasing government initiatives in this region also supported the growth of nebulizers market in the North American region. Asia-Pacific was observed to be an emerging market for nebulizers and is expected to grow at the highest CAGR from 2013 to 2019. This growth was mainly attributed due to presence of large patient pool diagnosed with chronic diseases such as asthma and chronic pulmonary obstructive diseases (COPD) in this region. Also, manufacturers are expanding their operations in Asian countries such as India, China, Japan and South Korea. For example, Omron Healthcare, Inc., established its subsidiary in South Korea to sell its nebulizers in this region. Thus, all the above mentioned factors collectively supports the growth of nebulizers market in Asia-Pacific region. Some of the key players having presence in the global nebulizers market are Philips Healthcare, Omron Healthcare, GF Health Products, Inc. and PARI Respiratory, Inc. Nebulizers Market, by Product Types - Pneumatic Nebulizer - Vented Pneumatic Nebulizers - Breath-Actuated Pneumatic Nebulizers - Ultrasonic Nebulizers - Stand Alone Ultrasonic Nebulizers - Portable Ultrasonic Nebulizers - Mesh Nebulizers - Static Mesh Nebulizers - Vibrating Mesh Nebulizers Company Profiles - Agilent Technologies, Inc. - Allied Healthcare Products, Inc. - CareFusion Corporation - Covidien plc - GE Healthcare Ltd. - GF Health Products, Inc. - Omron Healthcare, Inc. - PARI Respiratory Equipment, Inc. - Philips Healthcare For more information visit http://www.researchandmarkets.com/research/l9...ers_market
Dako Sponsors European Pathology Congress for Second Straight Year
GlobeNewswire - Fri Aug 29, 8:08AM CDT
Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, is again a major sponsor of the annual European Congress of Pathology.
Drug Discovery Technologies - A Global Market Overview
M2 - Fri Aug 29, 5:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dtdx3f/drug_discovery) has announced the addition of the "Drug Discovery Technologies - A Global Market Overview" report to their offering. The development of new drugs for treating difficult diseases, such as cancer requires extensive expenditure, in addition to consuming a lot of time. The first step in designing a new drug involves the utilizing high-throughput screening of large chemical libraries for identifying compounds that can provide the requisite therapeutic effect. The capability of visualizing biological activity at the cellular level has constituted a strategic component in drug discovery, and adding automation and high-volume screening methods has enabled in testing compounds in large numbers. The field of pharmaceutical research is being provided considerable impetus through the combination of imaging and screening. Key Topics Covered: PART A: GLOBAL MARKET PERSPECTIVE 1. INTRODUCTION 2. KEY MARKET TRENDS 3. RECENT PATENTS IN DRUG DISCOVERY LANDSCAPE 4. KEY GLOBAL PLAYERS 5. KEY BUSINESS TRENDS 6. GLOBAL MARKET OVERVIEW PART B: REGIONAL MARKET PERSPECTIVE 1. THE UNITED STATES 2. EUROPE 3. ASIA-PACIFIC 4. REST OF WORLD PART C: GUIDE TO THE INDUSTRY 1. NORTH AMERICA 2. EUROPE 3. ASIA-PACIFIC 4. REST OF WORLD PART
ANNEXURE 1. RESEARCH METHOLOGY 2. FEEDBACK Companies Mentioned: - 4-Antibody AG - Abbott Laboratories - Accelrys, Inc. - Affymetrix Inc. - Agilent Technologies Inc. - Asahi Kasei Pharma Corporation - Astrazeneca Plc - Aviva Biosciences Corp. - Bayer Healthcare AG - BD Biosciences - Beckman Coulter Inc. - Biacore International AB - Bioanalytical Systems, Inc. - Bio-Rad Laboratories, Inc. - Boehringer Ingelheim GmbH - Bristol-Myers Squibb Company - Caliper Life Sciences, Inc. - Caprion Proteomics, Inc. - Celera Corporation - Celgene Corporation - Charles River Laboratories International, Inc. - Compugen Ltd. - Decode Genetics, Inc. - EMD Millipore Corporation - Evotec AG - GE Healthcare Ltd. - Genedata AG - Hitgen Ltd - Hudson Robotics, Inc. - Illumina Inc. - Incyte Corporation - Isis Pharmaceuticals, Inc. - Kyowa Hakko Kirin Co., Ltd. - Luminex Corporation - Maxcyte, Inc - Merck & Co., Inc. - Millennium Pharmaceuticals, Inc. - Molecular Devices, LLC - Molecular Discovery Ltd. - Molecular Discovery Systems Pty., Ltd. - New England Biolabs, Inc. - Novartis AG - Osiris Therapeutics Inc. - Perkinelmer, Inc. - Promega Corporation - Qiagen N.V. - Quantum Pharmaceuticals - Roche Holding AG - Shimadzu Corporation - Sigma-Aldrich Corporation - Sri Biosciences - Tecan Group Ltd. - The National Center for Drug Screening - Thermo Fisher Scientific Inc. - Viva Biotech Ltd - Waters Corp. For more information visit http://www.researchandmarkets.com/research/dt..._discovery
Global Oscilloscope Industry Report 2014-2020
M2 - Thu Aug 28, 9:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qzdmmv/global) has announced the addition of the "Global Oscilloscope Industry Report 2014" report to their offering. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The oscilloscope market analysis is provided for both the international and Chinese domestic situations including development trends, competitive landscape analysis, key regions development status and a comparison analysis between the international and Chinese markets. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Oscilloscope industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on twenty-three industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The oscilloscope industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. Key Topics Covered: Chapter One Oscilloscope Industry Overview Chapter Two Asia Oscilloscope Market Analysis Chapter Three North America Oscilloscope Market Analysis Chapter Four Europe Oscilloscope Market Analysis Chapter Five Global Oscilloscope Market Analysis Chapter Six Oscilloscope Key Players Analysis Chapter Seven Oscilloscope Industry Development Trend Chapter Eight Oscilloscope New Project Investment Feasibility Analysis Chapter Nine Global Oscilloscope Industry Research Conclusions Companies Mentioned - Agilent Technologies Inc. - Danaher Corp. - Dataman Programmers Ltd - GAO Tek Incorporation - GW Instek - Hangzhou jingce Electronic Co. Ltd. - Hantek - MINIPA - OWON - PCE Iberica S.L. - RIGOL - Rohde & Schwarz GmbH & Co. - Shenzhen antaixin Electronic Co., Ltd. - TEXIO - Tekway - Teledyne LeCroy Inc. - Time Electronics - UNI-T - YangZhong wantai Electronic Instrument Co.,Ltd - Yangzhou Tuopu Electrical Technology Co., Ltd. - Yokogawa Electric - ZTEC Instruments - Fleet parts ltd. For more information visit http://www.researchandmarkets.com/research/qzdmmv/global
3 Reasons DuPont's Stock Could Rise
Maxx Chatsko, The Motley Fool - Motley Fool - Thu Aug 28, 9:30AM CDT
When investors think of a company founded in 1802 that is still wildly successful today and remains a major component of a large stock market index, they might have certain expectations for performance. It's important to remember, however, that no...
US Infectious Disease Molecular Diagnostics Market - Supplier Shares, Emerging Technologies & Competitive Landscape
M2 - Thu Aug 28, 5:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cp27n9/us_infectious) has announced the addition of the "US Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape" report to their offering. This new study contains 636 pages, 27 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. U.S. Market Overview: - Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by market segment. - Five-year test volume and sales projections. Market Segmentation Analysis: - Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. - Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. - A comprehensive analysis of the sequencing market by country and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers. Product/Technology Review: - Comparison of leading infectious disease molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Opportunities and Strategic Recommendations: - Specific new product development opportunities with potentially significant market appeal during the next five years. - Design criteria for new products. - Alternative market penetration strategies. - Potential market entry barriers and risks. - Business planning issues and concerns. Competitive Profiles - Abbott - Affymetrix - Agilent Technologies - Beckman Coulter/Danaher - Becton Dickinson - BioMerieux - Bio-Rad - Caliper - Cepheid - Decode - Diadexus - Exact Sciences - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Qiagen - Roche - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/cp...infectious
Chromatography (Instruments and Reagents) Global Market - Forecast to 2019
M2 - Thu Aug 28, 4:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pgdr6g/chromatography) has announced the addition of the "Chromatography (Instruments and Reagents) Global Market - Forecast to 2019" report to their offering. The chromatography reagents market is expected to grow at a CAGR of around 11% by 2019, while the instruments market is expected to grow at a CAGR of around 6%. The factors such as increase of global biotech and pharmaceutical firms, government funds and shares, technological advancements, and new product launches are the major drivers for the chromatography market. Whereas, high cost, need for the expertise professionals and presence of other substitute techniques are the factors limiting the chromatography market growth. However the increasing usage in monoclonal antibody purification, growing proteomics market and new products are providing the opportunities for the chromatography market growth. North America is considered to be the global leader in the chromatography market. The favourable growth is due to expansion of pharmaceutical and biotech firms. The rising government funding is boosting the market growth in the Asia-Pacific regions, which includes India, Singapore, Japan, China, Malaysia and Russia. The major players involved in the chromatography market are Agilent Technologies (U.S.), Thermofisher scientific, Inc. (U.S.), Waters Corporation (U.S.), Pall Corporation (U.S.), GE healthcare (U.K), Tosoh Corporation (Japan), W. R. Grace & Co (U.S.), Phenomenex, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.). Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Analysis 4. Chromatography Market by Instruments 5. Chromatography Market by Reagents 6. Regional Market Analysis 7. Company Developments 8. Major Company Profiles - Agilent Technologies - Bio-Rad Laboratories, Inc. - GE Healthcare - Life Technologies - Pall Corporation - Phenomenex, Inc. - Thermo Fisher Scientific, Inc. - Tosoh Corporation - W.R. Grace & Co. - Waters Corporation For more information visit http://www.researchandmarkets.com/research/pg...matography
Whole Exome Sequencing Market to 2018: Product (Systems, Kits, Library Preparation, Target Enrichment), Services (Sequencing), Technology (Sequencing by Synthesis) & Application (Cancer, Monogenic disorders)
M2 - Wed Aug 27, 9:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fgblbp/whole_exome) has announced the addition of the "Whole Exome Sequencing Market by Product, by Services, by Technology, by Application - Global Forecast to 2018" report to their offering. This global whole exome sequencing market was valued at $326.6 million in 2013 and is expected to grow at a CAGR of 22.0% from 2013 to 2018, to reach $884.1 million by 2018. The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America is expected to maintain its leadership in the market in the coming years. Growth in the North American market is likely to be driven by factors such as the increasing use of exome sequencing in rare disease research, increased government funding, and large number of sequencing-related conferences and annual meetings hosted by the U.S. The global whole exome sequencing market is categorized into five broad segments, namely, products and services, technologies, applications, end users, and geography. The global WES products and services market, by products, comprises systems and kits. The kits market is further segmented into DNA fragmentation, end repair, A-tailing, size selection kits, library preparation kits, and target enrichment kits. The WES products and services market, by services, comprises sequencing and data analysis services. The services market accounted for the largest share of the global WES products and services market in 2013. The whole exome sequencing market, by applications, includes diagnostics, drug discovery and development, personalized medicine, and animal and plant research. In 2013, the diagnostics market held the largest share of the global WES applications market. The market, by end users, comprises research centers, academic and government institutions, hospitals and clinics, and pharmaceutical and biotech companies, among others. In 2013, research centers and academic and government institutions accounted for the largest share of the global market, by end users. On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia and Rest of the World (RoW). Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Whole Exome Sequencing Market, By Products and Services 5 Global Whole Exome Sequencing Market, By Technology 6 Whole Exome Sequencing Market, By Application 7 Global Wholeexome Sequencing Market, By End User 8 Global Whole Exome Sequencing Market, By Geography 9 Competitive Landscape 10 Company Profiles - Agilent Technologies, Inc. - Ambry Genetics - Beijing Genomics Institute (Bgi) - Eurofins Genomics, Inc. - Genewiz, Inc. - Illumina, Inc. - Knome, Inc. - Macrogen, Inc. - Roche Nimblegen, Inc. - Sengenics - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/fg...hole_exome
Next Generation Sequencing (Genome/Exome sequencing/DNA sequencing) Global market - Forecast to 2020
M2 - Wed Aug 27, 6:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ljl4p3/next_generation) has announced the addition of the "Next Generation Sequencing (Genome/Exome sequencing/DNA sequencing) Global market - Forecast to 2020" report to their offering. The global next generation sequencing market is mainly categorized into pre-sequencing, NGS platforms and services, NGS data analysis, and storage and management. Next generation sequencing market is one of the fastest growing segments in the genomics market with an estimated CAGR of around 17.0% in the next five years. The major factors such as rapid adoption of this technology by researchers and its usability as a substitute of microarray technology in addition to its higher throughput, increased accuracy, and affordable costs are driving the next generation sequencing market growth. However, factors such as reducing capital expenditure from academic institutions and huge dependability on grants funding from the government are hampering the next generation sequencing market growth. In addition, the analysis of large amount of data generated by sequencers, and data storage and management is posing a major challenge. The growth opportunities of this market include cloud computing, rising demand for pre-sequencing, developments in NGS fully integrated instruments and rising nanopore sequencing technology. There is a huge opportunity for this technology in the field of drug discovery, personalized medicine, agricultural and animal research. The North American region accounts for the largest share of the next generation sequencing market. The European and Asian markets are also expected to grow due to the favorable funding from the government to adopt this technology. The major factors contributing to this market growth include rising adoption by new customers, rising adoption of high-throughput sequencing platforms by government organizations such as Biotechnology and Biological Sciences Research Council (BBSRC) (U.K.) and NHGRI (National Human Genome Research Institute) (U.S.). Key Topics Covered: 1. Executive summary 2. Introduction 3. Market Analysis 4. Next Generation Sequencing market, by technology 5. Next Generation Sequencing market, by products 6. Next Generation Sequencing market, by application 7. Next Generation Sequencing market, by end users 8. Regional Market analysis 9. Company Developments 10. Major Company Profiles - Agilent Technologies, Inc. - Beijing Genome Institute - Biomatters, Ltd. - Genomatix Software Gmbh - Illumina Inc. - Life Technologies Corp. - Pacific Biosciences of California Inc. - QIAGEN N.V - Roche Holding Ltd. - Strand Life Sciences Pvt. Ltd. For more information visit http://www.researchandmarkets.com/research/lj...generation
Microfluidic Device System Market 2013 - 2019
M2 - Wed Aug 27, 3:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/x345bg/microfluidic) has announced the addition of the "Microfluidic Device System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global microfluidic device market was valued at USD 1,531.2 million in 2013. It is likely to grow at a CAGR of 22.8% during 2013 to 2019 to reach USD 5,246.4 million in 2019. Microfluidics is an evolving scientific field with numerous analytical applications and commercial potential. Globally, the microfluidic device market is witnessing significant growth due to increasing R&D investment in pharmaceuticals, life science and rising point of care testing demand. New trends in healthcare, such as healthcare at home, supports point of care testing (POCT) as the most efficient and effective delivery of healthcare. It has many applications in other areas such as drug screening, sugar testers, chemical micro reactor, microprocessor cooling and micro fuel cells. Rising demand for point of care testing, miniaturization of chip, and increasing demand for microfluidic devices in genomics and proteomics are the key growth drivers for the microfluidic device market. In addition, change in material mix would provide opportunity for new market entrants, which would further drive the growth of the microfluidic device market. North America was valued at USD 644.5 million in 2013 and is expected to reach USD 2,095.5 million in 2019, growing at a CAGR of 21.7% from 2013 to 2019. In-vitro diagnostics microfluidic device market was valued at USD 949.6 million in 2013 and is expected to reach USD 3,317.4 million in 2019, growing at a CAGR of 23.2% from 2013 to 2019. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Industry Analysis Chapter 4 Market Trends Chapter 5 Porters Five Force Analysis Chapter 6 Global Market Size and Forecast Chapter 7 Segment Analysis - by Material Chapter 8 Segment Analysis - by Industry Chapter 9 Segment Analysis - by Application Chapter 10 Regional Analysis Chapter 11 Competitive Landscape Chapter 12 Company Profiles - Abbott Laboratories - Agilent Technologies Inc - Becton, Dickinson and Company - Bio- Rad Laboratories - Cepheid - Dolomite Centre - Fluidigm Corporation - Johnson & Johnson - Micronit Microfluidics - RainDance Technologies - Roche Diagnostics - Siemens Healthcare For more information visit http://www.researchandmarkets.com/research/x3...crofluidic
Global Lab Automation Market - Forecast to 2020
M2 - Tue Aug 26, 10:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8v7q34/lab_automation) has announced the addition of the "Lab Automation Global Market - Forecast to 2020" report to their offering. The laboratory automation market is expected to grow at a CAGR rate of around 7.0% from 2014 to 2019 The factors that contributes for the market growth include rise in diagnosis owing to work pressure, shortage of quality lab technicians, accuracy of the results, budget constraints for laboratories, time delay and labor cost. However the changes in reimbursement policies, high cost of equipment, affordability by small players, users shift from traditional procedures to automation are hampering the growth of the market. Although, lack of flexibility and adoptability in the existing lab automated systems pose a threat for the market, there is a big need for the market to grow as latest diagnostic technologies demand for new and sophisticated automated systems in the coming years. New market segments such as automation options in microbiology and hematology are providing more opportunities for the market growth. North America holds the largest market share of laboratory automation process followed by Europe, Asia and rest of the world. U.S. tops the chart due to its aging population, high diagnosis rate, and large volume of test samples compelling the clinical diagnostic laboratories to shift for automation process. The emerging economies are the fastest growing in the market because of its growing economy, rising health care awareness and increasing investment in corporate and academic research. Key Topics Covered: 1. Executive summary 2. Introduction 3. Market Analysis 4. Laboratory Automation Market, by Applications 6. Laboratory Automation Market, By End Users 7. Laboratory Automation Market, By Hardware 8. Laboratory Automation Market, By Software 9. Geographic Analysis 10. Competitive Landscape 11. Company Profiles - Abbott Diagnostics - Agilent Technologies - Biotek Instruments, Inc. - Danaher Corp - Hamilton Robotics, Inc - Labware, Inc. - PerkinElmer, Inc. - Siemens Healthcare - Tecan Group Ltd - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/8v...automation
Agilent Technologies and Shimadzu Enable Control of Each Other's GC Instruments in Their Respective Chromatographic Data Systems
PRWeb - Mon Aug 25, 8:10AM CDT
Agilent Technologies, Inc. and Shimadzu Corp. today announced the release of GC instrument control for their respective Chromatography Data Systems (CDS). This provides customers in analytical laboratories with more freedom of choice when selecting a chromatography data system.
Dako Sponsors Largest Histology Congress for 34th Year in a Row
GlobeNewswire - Mon Aug 25, 8:10AM CDT
Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, is a sponsor of this year's National Society for Histotechnology (NSH) Symposium.
5 Things Danaher Corp.'s Management Wants You to Know
Lee Samaha, The Motley Fool - Motley Fool - Mon Aug 25, 7:05AM CDT
Investors in Danaher saw the company deliver a disappointing set of second-quarter results that caused the stock to drop notably. In fact, as of today, it's pretty much flat on a six-month basis. In truth, the results weren't that bad: The...
TRADE NEWS: Keysight Technologies Announces Best-in-Class Femto/Picoammeters and Electrometers for Research and Development of New Materials
Business Wire - Tue Sep 02, 10:00AM CDT
Keysight Technologies, Inc. today introduced the B2980A Series of femto/picoammeters and electrometers, the world's first graphical picoammeters and electrometers to confidently measure down to 0.01 fA which is 0.01 x 10-15 A, and up to 10 petaohms (P) which is 10 x 10(15) ohms.
Agilent Technologies Introduces Higher-Performance Q-TOF GC/MS System, Featuring Optimized Hardware/Software Capabilities
Business Wire - Tue Sep 02, 10:00AM CDT
Agilent Technologies Inc. (NYSE:A) today introduced the 7200B Quadrupole Time of Flight (Q-TOF) Gas Chromatography Mass Spectrometer (GC/MS) System. The system replaces the company's most advanced GC/QTOF, the 7200A, with new capabilities that will significantly boost laboratory performance.
Microlease Unveils Certified Pre-Owned Program
Business Wire - Tue Sep 02, 7:01AM CDT
Microlease, Inc. today announced the launch of Microlease Certified Pre-Owned, a comprehensive program to address growing customer demand for quality test instruments with guarantees and calibration. Microlease Certified Pre-Owned will include instruments from leading manufacturers including Keysight Technologies (formerly Agilent Technologies), Tektronix, JDSU, Anritsu, Rohde & Schwarz, and Keithley, among others.
Agilent Technologies the ClearSeq AML for next generation cancer research
M2 - Tue Sep 02, 3:51AM CDT
Agilent Technologies Inc (NYSE: A), a chemical analysis, life sciences, diagnostics, electronics and communications company, today introduced ClearSeq AML, the first product in the ClearSeq line of next-generation cancer research panels, which targets 48 selected exons in 20 of the most commonly mutated genes found in acute myeloid leukemia.
Agilent Technologies Introduces Next-Generation Sequencing Cancer Research Panels
Business Wire - Tue Sep 02, 2:30AM CDT
Agilent Technologies Inc. (NYSE: A) today introduced ClearSeq AML, the first product in the ClearSeq line of next-generation cancer research panels, which targets 48 selected exons in 20 of the most commonly mutated genes found in acute myeloid leukemia.
Dako Launches Fast HER2 ISH Assay for New Automated Staining Platform in Europe
GlobeNewswire - Mon Sep 01, 8:13AM CDT
Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics , today announced the EU launch of HER2 IQFISH pharmDx automated on Dako Omnis.
Global Nebulizers Market Industry Analysis 2014-2019 - Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers
M2 - Mon Sep 01, 3:38AM CDT
Research and Markets (http://www.researchandmarkets.com/research/l9s298/nebulizers_market) has announced the addition of the "Nebulizers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global nebulizers market was valued at USD 610.0 million in 2012 and is expected to grow at a CAGR of 6.5% from 2013 to 2019, to reach an estimated value of USD 937.7 million by 2019. The global nebulizers market is segmented based on product types into pneumatic nebulizer, ultrasonic nebulizer and mesh nebulizer. In 2012, pneumatic nebulizer accounted for the largest market share of the global nebulizers market owing to its cost effective nature and easy to handle. Pneumatic nebulizers are further classified as vented and breath-actuated pneumatic nebulizers. In 2012, breath actuated pneumatic nebulizers segment accounted for the largest share of the global pneumatic nebulizers market due to factors such as cost effectiveness and efficient drug delivery. Moreover, the breath-actuated pneumatic nebulizers segment is expected to grow at the highest CAGR from 2013 to 2019 in the global pneumatic nebulizers market. Ultrasonic nebulizers are further segmented into standalone and portable ultrasonic nebulizers. Portable ultrasonic nebulizers accounted for the largest share as they are easy to handle and operate. North America accounted for the largest share in the global nebulizers market in 2012 owing to rising prevalence of respiratory diseases such as asthma, COPD and cystic fibrosis. In addition, increasing government initiatives in this region also supported the growth of nebulizers market in the North American region. Asia-Pacific was observed to be an emerging market for nebulizers and is expected to grow at the highest CAGR from 2013 to 2019. This growth was mainly attributed due to presence of large patient pool diagnosed with chronic diseases such as asthma and chronic pulmonary obstructive diseases (COPD) in this region. Also, manufacturers are expanding their operations in Asian countries such as India, China, Japan and South Korea. For example, Omron Healthcare, Inc., established its subsidiary in South Korea to sell its nebulizers in this region. Thus, all the above mentioned factors collectively supports the growth of nebulizers market in Asia-Pacific region. Some of the key players having presence in the global nebulizers market are Philips Healthcare, Omron Healthcare, GF Health Products, Inc. and PARI Respiratory, Inc. Nebulizers Market, by Product Types - Pneumatic Nebulizer - Vented Pneumatic Nebulizers - Breath-Actuated Pneumatic Nebulizers - Ultrasonic Nebulizers - Stand Alone Ultrasonic Nebulizers - Portable Ultrasonic Nebulizers - Mesh Nebulizers - Static Mesh Nebulizers - Vibrating Mesh Nebulizers Company Profiles - Agilent Technologies, Inc. - Allied Healthcare Products, Inc. - CareFusion Corporation - Covidien plc - GE Healthcare Ltd. - GF Health Products, Inc. - Omron Healthcare, Inc. - PARI Respiratory Equipment, Inc. - Philips Healthcare For more information visit http://www.researchandmarkets.com/research/l9...ers_market
Dako Sponsors European Pathology Congress for Second Straight Year
GlobeNewswire - Fri Aug 29, 8:08AM CDT
Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, is again a major sponsor of the annual European Congress of Pathology.
Drug Discovery Technologies - A Global Market Overview
M2 - Fri Aug 29, 5:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dtdx3f/drug_discovery) has announced the addition of the "Drug Discovery Technologies - A Global Market Overview" report to their offering. The development of new drugs for treating difficult diseases, such as cancer requires extensive expenditure, in addition to consuming a lot of time. The first step in designing a new drug involves the utilizing high-throughput screening of large chemical libraries for identifying compounds that can provide the requisite therapeutic effect. The capability of visualizing biological activity at the cellular level has constituted a strategic component in drug discovery, and adding automation and high-volume screening methods has enabled in testing compounds in large numbers. The field of pharmaceutical research is being provided considerable impetus through the combination of imaging and screening. Key Topics Covered: PART A: GLOBAL MARKET PERSPECTIVE 1. INTRODUCTION 2. KEY MARKET TRENDS 3. RECENT PATENTS IN DRUG DISCOVERY LANDSCAPE 4. KEY GLOBAL PLAYERS 5. KEY BUSINESS TRENDS 6. GLOBAL MARKET OVERVIEW PART B: REGIONAL MARKET PERSPECTIVE 1. THE UNITED STATES 2. EUROPE 3. ASIA-PACIFIC 4. REST OF WORLD PART C: GUIDE TO THE INDUSTRY 1. NORTH AMERICA 2. EUROPE 3. ASIA-PACIFIC 4. REST OF WORLD PART
ANNEXURE 1. RESEARCH METHOLOGY 2. FEEDBACK Companies Mentioned: - 4-Antibody AG - Abbott Laboratories - Accelrys, Inc. - Affymetrix Inc. - Agilent Technologies Inc. - Asahi Kasei Pharma Corporation - Astrazeneca Plc - Aviva Biosciences Corp. - Bayer Healthcare AG - BD Biosciences - Beckman Coulter Inc. - Biacore International AB - Bioanalytical Systems, Inc. - Bio-Rad Laboratories, Inc. - Boehringer Ingelheim GmbH - Bristol-Myers Squibb Company - Caliper Life Sciences, Inc. - Caprion Proteomics, Inc. - Celera Corporation - Celgene Corporation - Charles River Laboratories International, Inc. - Compugen Ltd. - Decode Genetics, Inc. - EMD Millipore Corporation - Evotec AG - GE Healthcare Ltd. - Genedata AG - Hitgen Ltd - Hudson Robotics, Inc. - Illumina Inc. - Incyte Corporation - Isis Pharmaceuticals, Inc. - Kyowa Hakko Kirin Co., Ltd. - Luminex Corporation - Maxcyte, Inc - Merck & Co., Inc. - Millennium Pharmaceuticals, Inc. - Molecular Devices, LLC - Molecular Discovery Ltd. - Molecular Discovery Systems Pty., Ltd. - New England Biolabs, Inc. - Novartis AG - Osiris Therapeutics Inc. - Perkinelmer, Inc. - Promega Corporation - Qiagen N.V. - Quantum Pharmaceuticals - Roche Holding AG - Shimadzu Corporation - Sigma-Aldrich Corporation - Sri Biosciences - Tecan Group Ltd. - The National Center for Drug Screening - Thermo Fisher Scientific Inc. - Viva Biotech Ltd - Waters Corp. For more information visit http://www.researchandmarkets.com/research/dt..._discovery Global Oscilloscope Industry Report 2014-2020
M2 - Thu Aug 28, 9:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qzdmmv/global) has announced the addition of the "Global Oscilloscope Industry Report 2014" report to their offering. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The oscilloscope market analysis is provided for both the international and Chinese domestic situations including development trends, competitive landscape analysis, key regions development status and a comparison analysis between the international and Chinese markets. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Oscilloscope industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on twenty-three industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The oscilloscope industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. Key Topics Covered: Chapter One Oscilloscope Industry Overview Chapter Two Asia Oscilloscope Market Analysis Chapter Three North America Oscilloscope Market Analysis Chapter Four Europe Oscilloscope Market Analysis Chapter Five Global Oscilloscope Market Analysis Chapter Six Oscilloscope Key Players Analysis Chapter Seven Oscilloscope Industry Development Trend Chapter Eight Oscilloscope New Project Investment Feasibility Analysis Chapter Nine Global Oscilloscope Industry Research Conclusions Companies Mentioned - Agilent Technologies Inc. - Danaher Corp. - Dataman Programmers Ltd - GAO Tek Incorporation - GW Instek - Hangzhou jingce Electronic Co. Ltd. - Hantek - MINIPA - OWON - PCE Iberica S.L. - RIGOL - Rohde & Schwarz GmbH & Co. - Shenzhen antaixin Electronic Co., Ltd. - TEXIO - Tekway - Teledyne LeCroy Inc. - Time Electronics - UNI-T - YangZhong wantai Electronic Instrument Co.,Ltd - Yangzhou Tuopu Electrical Technology Co., Ltd. - Yokogawa Electric - ZTEC Instruments - Fleet parts ltd. For more information visit http://www.researchandmarkets.com/research/qzdmmv/global
3 Reasons DuPont's Stock Could Rise
Maxx Chatsko, The Motley Fool - Motley Fool - Thu Aug 28, 9:30AM CDT
When investors think of a company founded in 1802 that is still wildly successful today and remains a major component of a large stock market index, they might have certain expectations for performance. It's important to remember, however, that no...
US Infectious Disease Molecular Diagnostics Market - Supplier Shares, Emerging Technologies & Competitive Landscape
M2 - Thu Aug 28, 5:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cp27n9/us_infectious) has announced the addition of the "US Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape" report to their offering. This new study contains 636 pages, 27 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. U.S. Market Overview: - Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by market segment. - Five-year test volume and sales projections. Market Segmentation Analysis: - Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. - Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. - A comprehensive analysis of the sequencing market by country and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers. Product/Technology Review: - Comparison of leading infectious disease molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Opportunities and Strategic Recommendations: - Specific new product development opportunities with potentially significant market appeal during the next five years. - Design criteria for new products. - Alternative market penetration strategies. - Potential market entry barriers and risks. - Business planning issues and concerns. Competitive Profiles - Abbott - Affymetrix - Agilent Technologies - Beckman Coulter/Danaher - Becton Dickinson - BioMerieux - Bio-Rad - Caliper - Cepheid - Decode - Diadexus - Exact Sciences - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Qiagen - Roche - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/cp...infectious
Chromatography (Instruments and Reagents) Global Market - Forecast to 2019
M2 - Thu Aug 28, 4:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pgdr6g/chromatography) has announced the addition of the "Chromatography (Instruments and Reagents) Global Market - Forecast to 2019" report to their offering. The chromatography reagents market is expected to grow at a CAGR of around 11% by 2019, while the instruments market is expected to grow at a CAGR of around 6%. The factors such as increase of global biotech and pharmaceutical firms, government funds and shares, technological advancements, and new product launches are the major drivers for the chromatography market. Whereas, high cost, need for the expertise professionals and presence of other substitute techniques are the factors limiting the chromatography market growth. However the increasing usage in monoclonal antibody purification, growing proteomics market and new products are providing the opportunities for the chromatography market growth. North America is considered to be the global leader in the chromatography market. The favourable growth is due to expansion of pharmaceutical and biotech firms. The rising government funding is boosting the market growth in the Asia-Pacific regions, which includes India, Singapore, Japan, China, Malaysia and Russia. The major players involved in the chromatography market are Agilent Technologies (U.S.), Thermofisher scientific, Inc. (U.S.), Waters Corporation (U.S.), Pall Corporation (U.S.), GE healthcare (U.K), Tosoh Corporation (Japan), W. R. Grace & Co (U.S.), Phenomenex, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.). Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Analysis 4. Chromatography Market by Instruments 5. Chromatography Market by Reagents 6. Regional Market Analysis 7. Company Developments 8. Major Company Profiles - Agilent Technologies - Bio-Rad Laboratories, Inc. - GE Healthcare - Life Technologies - Pall Corporation - Phenomenex, Inc. - Thermo Fisher Scientific, Inc. - Tosoh Corporation - W.R. Grace & Co. - Waters Corporation For more information visit http://www.researchandmarkets.com/research/pg...matography
Whole Exome Sequencing Market to 2018: Product (Systems, Kits, Library Preparation, Target Enrichment), Services (Sequencing), Technology (Sequencing by Synthesis) & Application (Cancer, Monogenic disorders)
M2 - Wed Aug 27, 9:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fgblbp/whole_exome) has announced the addition of the "Whole Exome Sequencing Market by Product, by Services, by Technology, by Application - Global Forecast to 2018" report to their offering. This global whole exome sequencing market was valued at $326.6 million in 2013 and is expected to grow at a CAGR of 22.0% from 2013 to 2018, to reach $884.1 million by 2018. The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America is expected to maintain its leadership in the market in the coming years. Growth in the North American market is likely to be driven by factors such as the increasing use of exome sequencing in rare disease research, increased government funding, and large number of sequencing-related conferences and annual meetings hosted by the U.S. The global whole exome sequencing market is categorized into five broad segments, namely, products and services, technologies, applications, end users, and geography. The global WES products and services market, by products, comprises systems and kits. The kits market is further segmented into DNA fragmentation, end repair, A-tailing, size selection kits, library preparation kits, and target enrichment kits. The WES products and services market, by services, comprises sequencing and data analysis services. The services market accounted for the largest share of the global WES products and services market in 2013. The whole exome sequencing market, by applications, includes diagnostics, drug discovery and development, personalized medicine, and animal and plant research. In 2013, the diagnostics market held the largest share of the global WES applications market. The market, by end users, comprises research centers, academic and government institutions, hospitals and clinics, and pharmaceutical and biotech companies, among others. In 2013, research centers and academic and government institutions accounted for the largest share of the global market, by end users. On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia and Rest of the World (RoW). Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Whole Exome Sequencing Market, By Products and Services 5 Global Whole Exome Sequencing Market, By Technology 6 Whole Exome Sequencing Market, By Application 7 Global Wholeexome Sequencing Market, By End User 8 Global Whole Exome Sequencing Market, By Geography 9 Competitive Landscape 10 Company Profiles - Agilent Technologies, Inc. - Ambry Genetics - Beijing Genomics Institute (Bgi) - Eurofins Genomics, Inc. - Genewiz, Inc. - Illumina, Inc. - Knome, Inc. - Macrogen, Inc. - Roche Nimblegen, Inc. - Sengenics - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/fg...hole_exome
Next Generation Sequencing (Genome/Exome sequencing/DNA sequencing) Global market - Forecast to 2020
M2 - Wed Aug 27, 6:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ljl4p3/next_generation) has announced the addition of the "Next Generation Sequencing (Genome/Exome sequencing/DNA sequencing) Global market - Forecast to 2020" report to their offering. The global next generation sequencing market is mainly categorized into pre-sequencing, NGS platforms and services, NGS data analysis, and storage and management. Next generation sequencing market is one of the fastest growing segments in the genomics market with an estimated CAGR of around 17.0% in the next five years. The major factors such as rapid adoption of this technology by researchers and its usability as a substitute of microarray technology in addition to its higher throughput, increased accuracy, and affordable costs are driving the next generation sequencing market growth. However, factors such as reducing capital expenditure from academic institutions and huge dependability on grants funding from the government are hampering the next generation sequencing market growth. In addition, the analysis of large amount of data generated by sequencers, and data storage and management is posing a major challenge. The growth opportunities of this market include cloud computing, rising demand for pre-sequencing, developments in NGS fully integrated instruments and rising nanopore sequencing technology. There is a huge opportunity for this technology in the field of drug discovery, personalized medicine, agricultural and animal research. The North American region accounts for the largest share of the next generation sequencing market. The European and Asian markets are also expected to grow due to the favorable funding from the government to adopt this technology. The major factors contributing to this market growth include rising adoption by new customers, rising adoption of high-throughput sequencing platforms by government organizations such as Biotechnology and Biological Sciences Research Council (BBSRC) (U.K.) and NHGRI (National Human Genome Research Institute) (U.S.). Key Topics Covered: 1. Executive summary 2. Introduction 3. Market Analysis 4. Next Generation Sequencing market, by technology 5. Next Generation Sequencing market, by products 6. Next Generation Sequencing market, by application 7. Next Generation Sequencing market, by end users 8. Regional Market analysis 9. Company Developments 10. Major Company Profiles - Agilent Technologies, Inc. - Beijing Genome Institute - Biomatters, Ltd. - Genomatix Software Gmbh - Illumina Inc. - Life Technologies Corp. - Pacific Biosciences of California Inc. - QIAGEN N.V - Roche Holding Ltd. - Strand Life Sciences Pvt. Ltd. For more information visit http://www.researchandmarkets.com/research/lj...generation
Microfluidic Device System Market 2013 - 2019
M2 - Wed Aug 27, 3:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/x345bg/microfluidic) has announced the addition of the "Microfluidic Device System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global microfluidic device market was valued at USD 1,531.2 million in 2013. It is likely to grow at a CAGR of 22.8% during 2013 to 2019 to reach USD 5,246.4 million in 2019. Microfluidics is an evolving scientific field with numerous analytical applications and commercial potential. Globally, the microfluidic device market is witnessing significant growth due to increasing R&D investment in pharmaceuticals, life science and rising point of care testing demand. New trends in healthcare, such as healthcare at home, supports point of care testing (POCT) as the most efficient and effective delivery of healthcare. It has many applications in other areas such as drug screening, sugar testers, chemical micro reactor, microprocessor cooling and micro fuel cells. Rising demand for point of care testing, miniaturization of chip, and increasing demand for microfluidic devices in genomics and proteomics are the key growth drivers for the microfluidic device market. In addition, change in material mix would provide opportunity for new market entrants, which would further drive the growth of the microfluidic device market. North America was valued at USD 644.5 million in 2013 and is expected to reach USD 2,095.5 million in 2019, growing at a CAGR of 21.7% from 2013 to 2019. In-vitro diagnostics microfluidic device market was valued at USD 949.6 million in 2013 and is expected to reach USD 3,317.4 million in 2019, growing at a CAGR of 23.2% from 2013 to 2019. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Industry Analysis Chapter 4 Market Trends Chapter 5 Porters Five Force Analysis Chapter 6 Global Market Size and Forecast Chapter 7 Segment Analysis - by Material Chapter 8 Segment Analysis - by Industry Chapter 9 Segment Analysis - by Application Chapter 10 Regional Analysis Chapter 11 Competitive Landscape Chapter 12 Company Profiles - Abbott Laboratories - Agilent Technologies Inc - Becton, Dickinson and Company - Bio- Rad Laboratories - Cepheid - Dolomite Centre - Fluidigm Corporation - Johnson & Johnson - Micronit Microfluidics - RainDance Technologies - Roche Diagnostics - Siemens Healthcare For more information visit http://www.researchandmarkets.com/research/x3...crofluidic
Global Lab Automation Market - Forecast to 2020
M2 - Tue Aug 26, 10:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8v7q34/lab_automation) has announced the addition of the "Lab Automation Global Market - Forecast to 2020" report to their offering. The laboratory automation market is expected to grow at a CAGR rate of around 7.0% from 2014 to 2019 The factors that contributes for the market growth include rise in diagnosis owing to work pressure, shortage of quality lab technicians, accuracy of the results, budget constraints for laboratories, time delay and labor cost. However the changes in reimbursement policies, high cost of equipment, affordability by small players, users shift from traditional procedures to automation are hampering the growth of the market. Although, lack of flexibility and adoptability in the existing lab automated systems pose a threat for the market, there is a big need for the market to grow as latest diagnostic technologies demand for new and sophisticated automated systems in the coming years. New market segments such as automation options in microbiology and hematology are providing more opportunities for the market growth. North America holds the largest market share of laboratory automation process followed by Europe, Asia and rest of the world. U.S. tops the chart due to its aging population, high diagnosis rate, and large volume of test samples compelling the clinical diagnostic laboratories to shift for automation process. The emerging economies are the fastest growing in the market because of its growing economy, rising health care awareness and increasing investment in corporate and academic research. Key Topics Covered: 1. Executive summary 2. Introduction 3. Market Analysis 4. Laboratory Automation Market, by Applications 6. Laboratory Automation Market, By End Users 7. Laboratory Automation Market, By Hardware 8. Laboratory Automation Market, By Software 9. Geographic Analysis 10. Competitive Landscape 11. Company Profiles - Abbott Diagnostics - Agilent Technologies - Biotek Instruments, Inc. - Danaher Corp - Hamilton Robotics, Inc - Labware, Inc. - PerkinElmer, Inc. - Siemens Healthcare - Tecan Group Ltd - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/8v...automation
Agilent Technologies and Shimadzu Enable Control of Each Other's GC Instruments in Their Respective Chromatographic Data Systems
PRWeb - Mon Aug 25, 8:10AM CDT
Agilent Technologies, Inc. and Shimadzu Corp. today announced the release of GC instrument control for their respective Chromatography Data Systems (CDS). This provides customers in analytical laboratories with more freedom of choice when selecting a chromatography data system.
Dako Sponsors Largest Histology Congress for 34th Year in a Row
GlobeNewswire - Mon Aug 25, 8:10AM CDT
Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, is a sponsor of this year's National Society for Histotechnology (NSH) Symposium.
5 Things Danaher Corp.'s Management Wants You to Know
Lee Samaha, The Motley Fool - Motley Fool - Mon Aug 25, 7:05AM CDT
Investors in Danaher saw the company deliver a disappointing set of second-quarter results that caused the stock to drop notably. In fact, as of today, it's pretty much flat on a six-month basis. In truth, the results weren't that bad: The...
